Cargando…

Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy

Adeno-associated virus (AAV) was first characterized as small “defective” contaminant particles in a simian adenovirus preparation in 1965. Since then, a recombinant platform of AAV (rAAV) has become one of the leading candidates for gene therapy applications resulting in two FDA-approved treatments...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bower, Jacquelyn J., Song, Liujiang, Bastola, Prabhakar, Hirsch, Matthew L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309980/ https://www.ncbi.nlm.nih.gov/pubmed/34201599 http://dx.doi.org/10.3390/v13071205

Ejemplares similares

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
por: Bastola, Prabhakar, et al.
Publicado: (2020)

Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy
por: Crabtree, Elizabeth, et al.
Publicado: (2022)

Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits
por: Song, Liujiang, et al.
Publicado: (2020)

My Pathway to Adeno-Associated Virus and Adeno-Associated Virus Gene Therapy: A Personal Perspective
por: Carter, Barrie J.
Publicado: (2020)

Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye
por: Gilger, Brian C., et al.
Publicado: (2022)

Efficacy of adeno-associated virus gene therapy in a MNGIE murine model enhanced by chronic exposure to nucleosides
por: Vila-Julià, Ferran, et al.
Publicado: (2020)

A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
por: Ellis, Brian L, et al.
Publicado: (2013)

Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
por: Aslanidi, George V., et al.
Publicado: (2013)

AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis
por: Crabtree, Elizabeth, et al.
Publicado: (2019)

Adeno-Associated Virus Gene Therapy for Liver Disease
por: Kattenhorn, Lisa M., et al.
Publicado: (2016)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2019)

Enhancement of Adeno-Associated Virus-Mediated Gene Therapy Using Hydroxychloroquine in Murine and Human Tissues
por: Chandler, Laurel C., et al.
Publicado: (2023)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
por: Hocquemiller, Michaël, et al.
Publicado: (2016)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma
por: Xu, Xin, et al.
Publicado: (2021)

A Fixed-Depth Microneedle Enhances Reproducibility and Safety for Corneal Gene Therapy
por: Gilger, Brian C., et al.
Publicado: (2020)

Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides
por: Liu, Yarong, et al.
Publicado: (2014)

Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies
por: Collins, Logan Thrasher, et al.
Publicado: (2023)

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
por: Large, Edward E., et al.
Publicado: (2023)

The state of the art of adeno-associated virus-based vectors in gene therapy
por: Coura, Renata dos Santos, et al.
Publicado: (2007)

Adeno-associated virus preferentially transduces human compared to mouse synovium
por: Jennings, K, et al.
Publicado: (2001)

Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis
por: Vyas, Meera, et al.
Publicado: (2023)

Correction: The state of the art of adeno-associated virus-based vectors in gene therapy
por: dos Santos Coura, Renata, et al.
Publicado: (2010)

Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases
por: Zhou, Kai, et al.
Publicado: (2022)

Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy
por: Gorovits, Boris, et al.
Publicado: (2023)

Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
por: Zhao, Liyuan, et al.
Publicado: (2023)

Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy
por: Chen, Siqi, et al.
Publicado: (2021)

Adeno‐associated virus‐vectored erythropoietin gene therapy for anemia in cats with chronic kidney disease
por: Vaden, Shelly L., et al.
Publicado: (2023)

Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics
por: Gardner, Matthew R.
Publicado: (2020)

Synthetic Biology: Emerging Concepts to Design and Advance Adeno‐Associated Viral Vectors for Gene Therapy
por: Wagner, Hanna J., et al.
Publicado: (2021)

The Role of the Adeno-Associated Virus Capsid in Gene Transfer
por: Van Vliet, Kim M., et al.
Publicado: (2008)

Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
por: Meumann, Nadja, et al.
Publicado: (2022)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases
por: Qu, Yuan, et al.
Publicado: (2019)

Ocular Gene Therapy with Adeno-associated Virus Vectors: Current Outlook for Patients and Researchers
por: Casey, Geoffrey A., et al.
Publicado: (2020)

Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR
por: Meyer, Nancy L, et al.
Publicado: (2019)

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia
por: Monahan, Paul E., et al.
Publicado: (2021)

Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia
por: May, Francis J., et al.
Publicado: (2021)

Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
por: Kotulska, Katarzyna, et al.
Publicado: (2021)

Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry
por: Wu, Di, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_alsgfad56teg5u1309j1q1fvem